logo

For the Inventor, By the Inventor

Lansdale, PA, United States of America

Steven D Young

This inventor holds 34 USPTO granted patents and 1 EPO patent, primarily in HIV Integrase Inhibitors. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Other. Active years: 1985-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven D Young. Retrieved from https://idiyas.com/inventor/steven-d-young

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 34

% Patents Active = 85.3


Average Co-Inventor Count = 3.6

ph-index = 16

Forward Citations = 675(Granted Patents)


Company Filing History:

goldMedal31 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal1 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal2 out of 834,601 
Other
 patents

Years Active: 1985-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
HIV Integrase Inhibitors
Calcium Channel Blockers
Farnesyl-Protein Transferase
Quinazolinone Antagonists
Arylheteroaryl Inhibitors
Alpha1A Adrenergic Antagonists
Biaryl Substituted Imidazole
Fibrinogen Receptor Antagonists
Dioxobenzocyclo-Hepta-Pyridine
Spiro Hexahydro Arylquinolizines
Substituted Indeno Pyridines
Crystal Forms
34 patents (USPTO):Explore Patents
1. 7745452 - Quinazolinone T-type calcium channel antagonists (2010-06-29),
2. 7452893 - 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists (2008-11-18),
3. 7279487 - Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors (2007-10-09),
4. 6939964 - Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one (2005-09-06),
5. 6921759 - Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors (2005-07-26),
6. 6919351 - Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors (2005-07-19),
7. 6841558 - Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors (2005-01-11),
8. 6639071 - Crystal Forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one (2003-10-28),
9. 6380249 - HIV integrase inhibitors (2002-04-30),
10. 6306891 - HIV integrase inhibitors (2001-10-23),
11. 6262055 - HIV integrase inhibitors (2001-07-17),
12. 6093737 - Inhibitors of farnesyl-protein transferase (2000-07-25),
13. 6080870 - Biaryl substituted imidazole compounds useful as farnesyl-protein (2000-06-27),
14. 6077853 - Inhibitors of farnesyl-protein transferase (2000-06-20),
15. 5990107 - Fibrinogen receptor antagonist prodrugs (1999-11-23),

Hello! How may I help you today in the sphere of innovations, inventions, inventors, patent attorneys, and patents?

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…